| abstract |
Pharmaceutical combination of compositions and methods comprising aldose reductase inhibitors and glycogen phosphorylase inhibitors. The compositions and methods are useful for treating conditions of insulin resistance, such as diabetes, and for reducing tissue damage caused by ischemia. The compositions and methods are useful for the treatment of insulin resistant conditions such as diabetes and in reducing tissue damage due to ischemia. |